Mc. Wright et al., DEVELOPMENTAL-CHANGES IN THE CONSTITUTIVE AND INDUCIBLE EXPRESSION OFCYTOCHROME-P450 3A2, Biochemical pharmacology, 54(7), 1997, pp. 841-846
Using a CYP3A2-specific oligonucleotide and an antipeptide antibody ra
ised against the C terminus of CYP3A2 (VINGA) it is demonstrated that
metyrapone administration to adult (12 weeks old) but not immature (3
weeks old) male Sprague Dawley rats induces the hepatic expression of
CYP3A2 mRNA and protein. The constitutively expressed level of CYP3A2
protein in adult male rats is markedly lower than the levels expressed
in immature rats as determined using the anti-VINGA antibody, in cont
rast to previous reports using antibodies that do not discriminate bet
ween CYP3A forms. Hepatic microsomal CYP3A2 protein expression, examin
ed between 3 and 15 weeks of age, is extinguished between 9 and 12 wee
ks of age in contrast to immunoreactive CYP3A protein (determined usin
g a nonselective antibody) and CYP3A-dependent androstenedione 6 beta-
hydroxylase activity. These data suggest that the regulation of the in
duction of CYP3A2 is developmentally controlled and that the major exp
ressed adult form(s) of constitutively expressed CYP3A is not CYP3A2.
(C) 1997 Elsevier Science Inc.